Buntin g, S. & Moncada, S. (1980). Prostacyclin by preventing platelet activation prolongs activated clotting time in blood and platelet rich plasma and potentiates the anticoagulant

etTect of heparin.s-« J. Pharm ac., 69, 268p-269p.

Bunt ing, S., Moncada, S., Reed, P., Salmon, J. A. & Vane , J. R. (\978). An antiserum to 5,

6-dihydro prostacyclin (PGII)which also binds prostacyclin. Prosta glandins, 15, 565-574.

Bunt ing, S., Moncada , S. & Vane, J. R. (1976b). Th e etTects of prostaglandin endoperoxides and

thro mboxa ne A2 on strips of rabbit coeliac artery and other smooth muscle preparati ons.

Brit. J. Pharmac.. 57,462 P. .

Bunting, S., Moncada, S. & Vane, J. R. (1977). Antithrombotic properties of vascular

endothelium. Lancet, 2, 1075-1076.

Bunting, .S, Moncada, S., Vane , J. R., Wood s, H. F. & Weston , M. J. (\979) . Prostacyclin

improves haemocompatibility du ring charcoal haemoperfusion. In Prostacyclin, ed.

Vane,J. R. & Bergstrom , S., pp·361-369. New York: Ra ven Press.

Burch , J. W., Stanford, N. & Majerus, P. W. (\97 8). Inhibition ofplatelet prostaglandin synthetase by oral aspirin . J. clin. ln vest.. 61, 314-319.

Carlson, L. A. & Olsson, A. G. (1 976). Intravenous prostagiand in EI in severe per ipheral

vascular disease. Lancet, 2, 810.

Chapple, D. J., Dusting, G. J., Hughes, R. & Vane ,J. R. (\978). A vagal reflex contributes to the

hypoten sive effect ofprostacyclin in anacsthetized dogs. J. Physiol., 281, 43-44p.

Chapple , D. J., Dusting, G. J., Hughes , R. & Vane, J. R. (\980). Some direct and reflex cardiovascular actions of prostacyclin (PGh) and PGE2 in anaesthetized dogs. Brit. J. Pharmac.,

68,437-447.

Chierchia, S., Ciabattoni, G., Cinotti, G., Maseri , A., Patrono, c., Pulgiese, F., Distante, A.,

Simonetti, I. & Bem ini, W. (\979) . Haemodynamic and anti-aggregatory effects ofprostacyclin (PGh) in the healthy man . Circulation, 59 and 60, Supp. Il p 83.

Cho , M. J. & Allen , M. A. (1978). Chemical stabil ity of prostacyclin in aqueous solution.

Prostaglandins, 15,943-954.

Christofmis, G. J., Moncada , S., Buntin g, S. & Vane , J. R. (1979). Prosta cyclin (PGb) release by

rabbit aorta and human umbil ical vein endothelial cells after prolonged subculture. In

Prostacyclin, ed. Vane ,J. R. & Bergstrom , S., pp 77-84. New York: Raven Press.

Cocean i, F., Bishai , 1., White, E., Bodach, E. & Olle y, P. M. (\97 8). Action ofprostaglandins,

endoperoxides and thromboxanes on the lamb ductus arteriosus. Am. J. Physiol.. 234,

HI17-HI22.

Czerv ionke , R. L., Hoak, J. C. & Fry, G. L. (1978). Effect of aspirin on thrombin-induced

adherence of platelets to cultured cells from the blood vessel walls. J. clin. In vest.. 62,

847-856.

Czervionke , R. L., Smith, J. 8. , Fry, G. L. & Hoak , J. C. (\979) . Inhibition ofprostacyclin by

treatment ofendothelium with aspirin. J. clin. Lnves t.. 63 ,1089-1092 .

Data,J. L., Crump, W. J., Hollifield ,J. W., Frolich, J. C. & Nies, A. S. (\976) . Prostaglandins: A

role in baroreceptor control ofrenin release. Clin. Res., 24, 397A.

Davison , E. M., Ford-Hutchinson, A. W., Smith, M. J. H. & Walker, J. R. (1978). The release of

thromboxane B2 by rabb it peritoneal polymorphonuclear leukocytes. Brit. J. Pharmac.,

63,407 P.

De Dekere, E. A. M., Nugteren, D. H. & Ten Hoor, F. (\977). Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart. Na/ure, 268, 160-163.

Dollery, C. T., Friedman, L. A., Hensby, C. N., Kohner, E., Lewis, P.J., Porta, M. & Webster,J.

(\979) . Circulating prostacyclin may be reduced in diabetes. Lancet, 2, 1365.

Du sting, G. J., Chapple, D. J., Hughes , R., Moncada, S. & Vane , J. R. (l978a). Prostacyclin

induces coronary vasodilatation in anaesthetised dogs. CardiovascularRes.. 12,720-730.

Du sting, G. J., Moncada, S. & Vane ,J. R. (1977a). Disappearance ofprostacyclin in the circulation ofthe dog. Brit.J. Pharmac., 62, 514-415 P.

Du sting, G . J., Moncada, S. & Vane , J. R. (l977b). Prostacyclin (PGX) is the endogenous

metabolite respon sible for relaxation of coronary arteries induced by arachidonic acid.

Prostaglandins, 13,3-15.

Dusting, G. J., Moncada, S. & Vane ,J. R. (1977c). Prostacyclin is a weak contractor of coronary

arteries in the pig. Eur. J. Pharmac., 45, 301-304.

Dusting, G. J., Moncada, S. & Vane, J. R. (l978b). Vascular actions ofarachidonic acid and its

metabolites in perfused mesenteric and femoral beds of the dog. Eur. J. Pharmac.. 49,

65-72.

28 S. MONCADA & J. R. VA NE

Dusting, G. J., Moncada, S. & Vane , J. R. (l978c) . Recirculation of prostacyclin (PGh) in the

dog. Brit. J. Pharmac.,64, 315-320.

Ferreira, S. H., Moncada, S. & Vane, J. R. (1971). Indomethacin and aspirin abolish prostagiandin release from the spleen. Nature New Biol., 231,237-239.

Ferreira, S. H. & Vane, J. R. (1967. Prostaglandins: Their disappearance from and release into

the circulation. Nature, 216, 868-873.

Fitzgerald, G. A., Friedman, L. A., Miyamori, 1., O'Grady, J. & Lewis, P. J. (1979). A doubleblind placebo controlled crossoverstudy of prostacyclin in man. Life Sci.. 25,665-672.

Flower, R. J. (1978). Steroidal anti-inflammatory drugs as inhibitors of phospholipase A2• In

Advances in Prostaglandin and Thromboxane Research. Vol. 3, ed. Paoletti, R. & .

Samuelsson, B., pp. 105-112. New York: Academic Press.

Friedenberg, W. R., Myers, W. 0 ., Plotka, E. D., Beathard, J. N., Kummer, D. J., Gatlin, P. F.,

Stoiber, D. L., Ray, J. F. & Sautter, R. D. (1978). Platelet dysfunction associated with

cardiopulmonary bypass . Ann. Thorac. Surg., 25,298-305.

Frolich, J. c., Hollifteld , J. W., Dormois, J.c, Frolich, B. L., Seyberth, H., Michelakis, A. M. &

Oates, J. A. (1976). Suppression ofplasma renin activity by indomethacin in man . Circulation Res., 39,447-452.

Gerber, J. G., Branch, R. A , Nies, A S., Gerkens, J. F., Shand, D. G., Hollifield, J. & Oates, J.

A. (1978). Prostaglandins and renin release . 11. Assessment of renin secretion following

infusion of PGh, E2 and D2 into the renal artery of anaesthetized dogs. Prostaglandins, 15,

81-88 .

Gimson, A E. S., Hughes, R. D., Mellon, P. J., Woods, H. F., Langley, P. G., Canalese, J.,

Williams, R. & Weston, M. J. (1980). Prostacyclin to prevent platelet activation during

charcoal haemoperfusion in fulminant hepatic failure . Lancet.L, 173-175.

Godal, H. c.,Eika , c.,Dybdahl, J. H., Daae, L. & Larsen, S. (1979). Aspirin and bleeding time .

Lancet, 1, 1236.

Goldstein, I. M., Malmsten, C. L., Kaplan, H. B., Kindahl, H., Samuelsson , B. & Weissman, G.

(1977). Thromboxane generation by stimulated human granulocytes: Inhibition by

glucocorticoids and superoxide dismutase. Clin. Res; 25, 518A.

Gordon, J. L. & Pearson, J. D. (1978). Effects ofsulphinpyrazone and aspirin on prostagiandin h

(prostacyclin) synthesis by endothelial cells. Brit.J. Pharmac., 64,481-483.

Gorman , R. R., Bundy, G. L., Peterson, D. c, Sun, F. F., Miller, O. V. & Fitzpatrick, F. A

(1977a). Inhibition of human platelet thromboxane synthetase by 9,Il-azoprosta-5,13-

dienoic acid . Proc. Nat. Acad. Sei. USA, 74,4007-4011.

Gorman, R. R., Bunting, S. & Miller, O. V. (l977b). Modulation of human platelet adenylate

cyclase by pro stacyclin (PGX). Prostaglandins, 13,377-388.

Grenier, F. C. & Smith, W. L. (1978). Formation of 6-keto-PGF, a by collecting tubule cells

isolated from rabbit renal papillac. Prostaglandins, 16, 759-772.

Gryglewski, R. J., Korbut, R. & Ocetkiewicz, A C. (l978a). De-aggregatory action of prostacyclin in vivoand its enhancement by theophylline. Prostaglandins, 15,637-644.

Gryglewski, R. J., Korbut, R. & Ocetkiewicz, A. C. (1978b). Generation ofprostacyclin by lungs

in vivoand its release into the arterial circulation. Nature, 273, 765-767.

Gryglewski, R. J., Korbut, R., Ocetkiewicz, A. C. & Stachwa, R. (1978c). In vivo method for

quantitation ofanti-platelet potency ofdrugs. Arch.Pharmakol., 302, 25-30.

Gryglewski, R. J., Szczeklik, A. & Nizankowski, R. (l978d). Antiplatelet action ofintravenous

infusion ofprostacyclin in man . Thromb. Res., 13, 153-163.

Gryglewski, R. J., Zmuda, A., Korbut, R., Krecioch, E. & Bieron, K. (1977). Selective inhibition

ofthromboxane A2 biosynthesis in blood platelets. Nature, 267,627-628.

Gullner, H-G., Cerletti, c.,Bartter, F. c.,Smith, J. 8. & Gill, J. R., Jr . (1979). Prostacyclin overproduction in Bartter's syndrome. Lancet, 2, 767-768.

Hamberg, M. & Samuelsson, 8. (1973). Detection and isolat ion ofan endoperoxide intermediate

in prostagiandin biosynthesis. Proc. Nat. Acad. Sei. USA, 70, 899-903.

Hamberg, M. & Samuelsson, B. (1974). Novel transformations of arachidonic acid in human

platelets. Proc. Nat. Acad. Sei. USA, 71, 3400-3404.

Hamberg, M., Svensson, J. & Samuelsson, B. (1975). Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Nat. Acad. Sei.

USA, 72,2994-2998.

Hamberg, M., Svensson, J., Wakabayashi, T. & Samuelsson, 8.(1974). Isolation and structure of

two prostagiandin endoperoxides that cause platelet aggregation. Proc. Nat. Acad. Sei.

USA, 71,345-349.

PROSTACYCLIN, PHARMACOLOGY AND CLINICAL POTENTIAL 29

Harrison, H. E., Reece, A. H. & Johnson, M. (1978). Decreased vascular prostacyc1in in experimental diabetes. Lift Sei., 23,351-356.

Harter, H. R., Burch, J. W., Majerus, P. W., Standford, N., Pelmes, J. A., Anderson, C. B. &

Weerts, C. A. (1979). Prevention ofthromboembolism in patients ofhaemodialysis by low

dose aspirin. New Eng. J. Med. , 301, 577-579.

Hensby, C. N., Barnes, P. J., Dollcry, C. T. & Dargie , H. (1979). Production ofö-oxo-PfIf', a by

human lung in vivo. Lancet, 2, 1162-1163.

Heyns , A. Du P., van den Berg, D. J., Potgieter, G. M. & Retief, F. P. (1974). The inhibition of

platelet aggregation by an aorta intima extract. Thromb. Diath. Haemorrh. (Stuug.), 32,

417-431.

Higgs, E. A., Moncada, S., Vane, J. R., Caen, J. P., Michel, H. & Tobelern, G . (1978). Effect of

prostacyclin (PGh) on platelet adhesion to rabbit arterial subendothelium. Prostaglandins, 16,17-22.

Higgs, G. A., Bunting, S., Moncada, S. & Vane, J. R. (1976). Polymorphonuclear leukocytes

produce thromboxane As-like activity during phagocytosis. Prostaglandins, 12, 749-757.

Higgs, G. A., Cardinal, D. c., Moncada, S. & Vane, J. R. (1979). Microcirculatory effects of

prostacyclin (PGh) in hamster cheek pouch. Microvasc . Res; 18,245-254.

Higgs, E. A., Higgs, G. A., Moncada, S. & Vane, J. R. (1978). Prostacyc1in (PGh) inhibits the

fonnation ofplatelet thrombi in arterioies and venules ofthe hamster cheek pouch. Brit J.

Pharmac., 63, 535-539.

Hili , T. W. K. & Moncada, S. (1979). The renal haemodynamic and excretory act ions of prostacyclin and 6-oxo-PGF1 a in ana esthetized dogs. Prostaglandins, 17,87-98.

Hili , T. W. K., Moncada, S. & Vane , J. R. (1978). Stimulation ofrenin release by prostacyc1in

(PGh) in anaesthetised dogs. In Abstracts VII International Congress Pharmacology, Paris , July, 1978, pp. 343. Oxford : Pergamon Press.

Hintze, T. H. & Kaley , G. (1977). Prostaglandins and the control ofblood flow in the canine

myocardium. Circulation Res., 40,313-320.

Hintze, T. H., Kaley, G., Martin, E. G. & Messina, E. J. (1978). PGh induces bradycardia in the

dog. Prostaglandins,15, 712.

Hyman, A. L., Kadowitz, P. J., Lands , W. E. M., Crawford, C. G., Fried, J. & Barton, J. (1978).

Coronary vasodilator activity of 13,14-dehydro prostacyclin methyl ester: Comparison

with prostacyclin and other prostanoids. Proc. Nat. Acad. Sei. USA , 75, 3522-3526.

Jobin, F. (1978). Acetylsalicylic acid, hemostasis and human thromboembolism. Sem. Thromb.

Haemost. 4, 199-240.

Johnson, M., Harrison, H. E., Raftery, A. T. & Eider, J. B. (1979). Vascular prostacyclin may be

reduced in diabetes in man. Lancet, 1, 325-326.

Johnson, M., Reece, A. H. & Harrison, H. E. (1978). Decreased vascular prostacyclin in experimental diabetes. In Abstracts VII Int ernational Congress ofPharmacology, Paris , 1978, pp

342 . Oxford: Pergamon Press.

Johnson, R. A., Morton, D. R., Kinner, J. H., Gonnan, R. R., McGuire, J. c., Sun, F. F.,

Whittaker, N., Bunting, S., Salmon, J., Moncada, S. & Vane, J. R. (1976). The chemical

structure ofprostaglandin X (prostacyclin). Prostaglandins, 12,915-928.

Jorgensen, K. A., Olesen, A. S., Dyerberg, J. &Stoffersen, E. (1979). Aspirin and bleeding time:

dependency ofage. Lancet, 2, 302 .

Kadowitz, P. J., Chapnick, B. M., Feigen, L. P., Hyman, A. L., Nelson, P. K. & Spannhake, E.

W. (1978). Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGh. J. app. Physiol., 45,408-413.

Kelton, 1. G., Hirsch, J., Carter, C. J. & Buchanan, M. R. (1978). Thrombogenic effect ofhigh

dose aspirin in rabbits; relationship to inhibition ofvessel wall synthesis ofprostaglandin h

like activity. J. clin.Invest., 62,892-895.

Korbut, R. & Moncada, S. (1978). Prostacyclin (PGh) and thromboxane A2 interaction in vivo.

Regulation by aspirin and relationship with antithrombotic therapy. Thromb. Res., 13,

489-500.

Kulkarni, P. S. & Eakins, K. E. (1976). N-0164 inhibits generation of thromboxane As-like

activity from prostaglandin endoperoxides by human platelet microsomes. Prostaglandins,

12,465-469.

Kulkarni, P. S., Roberts, R. & Needleman, P. (1976). Paradoxical endogenous synthesis of a

coronary dilating substance from arachidonate. Prostaglandins, 12, 337-353.

Lagarde, M. & Dechavanne, M. (1977). Increase of platelet prostaglandin cyclic endoperoxides

in thrombosis. Lancet, 1,88.

30 S. MON CAD A & J. R. VA NE

Larsson , c., Weber, P. & Anggard, E. (1974). Arachidonic acid increases and indomethacin

decreases plasma renin activity in the rabbit. E ur.J . Pharmac., 28, 391-394.

Lefer, A. M., Ogletree, M. L., Smith, J. B., Silver, M. J., Nicolaou , K. c, Bamette, W. E. &

Gasic, G. P. (1978). Prostac yclin: A potentially valuable agent for preserving myocard ial

tissues in acute myocardial ischaemia . Science, 200, 52-54.

Lerner, C. W. & Hessler, J. R. (1979). Pulmonary and systemic vascular effects of exogenous

prostaglandin h in fetal lambs. E ur.J. Pharmac., 54, 37-42.

Levy, S. V. (1978). Con tractile responses to prostacyclin (PG h) of isolated human saphenous

and rat venous tissue. Prostaglandins, 16,93-97.

Lewy, R. 1., Smith , J. 8. , Silver, M. J., Wiener, L. & Wal insky, P. (1979). Detection ofthromboxane B2 in periphe ral blood ofpatients with Prinzmetal's angina. Prostag/andin Med. , 2,

243-248.

Lieberman, G. E., Lewis, G. P. & Pete rs, T. J. (1977). A membrane-bound enzyme in rabb it

aorta capable ofinhibiting adenosine-diphosphate-induced platel et aggregation. Lancet, 2,

330--332.

Longmore, D. 8. , Bennett, G ., Gueirrara, D., Smith , H.,Bunting, S., Moncada, S., Reed, P.,

Read , N. G. & Vane , J. R. (1979). Prostacyclin: a solution to some problems of extracorporeal circ ulation. Lancet, 1, 1002-1005.

Maclntyre, D. E., Pearson, J. D. & Gordon, J. L. (1978). Stimulation ofprostacyclin production

in vascularcells. Nature, 271,549-551.

Majerus, P. W. (1976). Why aspirin? Circu/ation, 54, 357-359.

Marcus, A. J. (1978). The role of lipids in platelet function with particular reference to the

arachidonic acid pathway.J . Lipid Res., 19,793-826.

Masotti , G., Galanti, G ., Poggesi, L., Abbate, R. & Neri Semeri, G. G . (1979). Differential

inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet, 2,

1213-1216.

Mon cada, S., Bunt ing, S., Mullane, K. M., Thorogood, P., Vane , J. R., Raz , A. &

Needleman, P. (l977a). Imidazole: A select ive potent antagonist of thromboxane

synthetase. Prostag/andins, 13, 611-618.

Mon cada , S., G ryglewski, R. J., Bunt ing, S. & Vane , J. R. (l976a). An enz yme isolated from

arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits

platelet aggregation. Nature, 263, 663-665.

Mon cada, S., Gryglewski, R. J., Bunting, S. & Van e, J. R. (I976b). A lipid pero xide inh ibits the

enzyme in blood vesse1 microsomes that gene rates from prostaglandin endoperox ides the

substa nce (prostagiandin X) which prevents platelet aggregation . Prostag/andins, 12,

715-733.

Mon cada , S., Herman, A. G., Higgs, E. A. & Vane , J. R. (1977b). Differential formation of

pro stacyclin (PGX or PGh) by layers of the arterial wall. An explantion for the antithrombotic properties of vascular endothelium . Thromb. Res., 11,323-344.

Moncada , S., Korbut, R., Bunt ing, S. & Vane , J. R. (1978). Prostacyclin is a circulating

hormone. Nature, 273 , 767-768.

Mon cada , S., Needleman, P., Bunting, S. & Vane , J. R. (l976 c). Prostaglandin endoperoxide

and thromboxane generating systems and their se1ective inhibition. Prostag/andins, 12,

323-325.